Unlabelled: Obstructive sleep apnea (OSA) affects approximately 20% of Americans. Patients with undiagnosed OSA may experience obstructive episodes during conscious sedation for colonoscopy. The purpose of this investigation was to describe the risk of undiagnosed OSA using the Berlin Questionnaire and to identify the relationship between OSA risk and the number of provider interventions performed to relieve obstructive symptoms during sedation for colonoscopy.
Methods: Adult patients were enrolled from the gastroenterology clinic at the National Military Medical Center (N = 99). The Berlin Questionnaire was delivered and a brief health history obtained. Patients were observed for obstructive symptoms during sedation. Provider interventions were counted. 18 patients were monitored during their first night of sleep using a portable sleep monitor. Data were analyzed using the independent samples t-test, Chi-square, and Chi-square test for trend.
Results: The incidence of undiagnosed OSA was 40.4%. Patients with hypertension had a higher rate of a positive screen for OSA (70%) than those without hypertension (20.3%), chi2(1) = 3.87, P < .05. There was no statistical difference in the number of provider interventions between the 2 groups. Risk of undiagnosed OSA in this sample is large but it does not appear to be associated with episodes of obstructive symptoms requiring provider intervention.
Download full-text PDF |
Source |
---|
Sleep Biol Rhythms
January 2025
Department of Respiratory Medicine, School of Medicine, Fujita Health University, 1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192 Japan.
The purpose of this study was to evaluate how the first oral administration of suvorexant affects PSG results in patients with severe obstructive sleep apnea (OSA). Single-center, prospective study conducted in a nonrandomized, uncontrolled, unblinded fashion. Undiagnosed 64 patients with suspected OSA underwent first-night PSG, and 30 patients with severe OSA (Apnea Hypopnea Index [AHI] ≥ 30 events/h) underwent second-night PSG testing after administration of 15 mg suvorexant.
View Article and Find Full Text PDFJ Am Assoc Nurse Pract
October 2024
School of Nursing and Health Studies, University of Missouri Kansas City, Walton, Kansas.
Background: Obstructive sleep apnea (OSA) is an often overlooked, widespread disease and a public health concern. Evidence-based practice guidelines do not exist to guide primary care clinicians' OSA screening practices. Clinicians must be competent in OSA; however, clinicians lack competency about this disease.
View Article and Find Full Text PDFFront Neurol
December 2024
Zarathu Co., Ltd., Seoul, Republic of Korea.
Objectives: Obstructive sleep apnea (OSA) is a common sleep-related breathing disorder, yet many cases remain undiagnosed. The STOP-Bang questionnaire was developed to identify individuals at high risk of OSA. We aimed to investigate the prevalence of individuals with suspected OSA using the STOP-Bang risk stratification in the general population of South Korea.
View Article and Find Full Text PDFSensors (Basel)
December 2024
Department of Information Engineering, Università Politecnica delle Marche, Via Brecce Bianche 12, 60131 Ancona, Italy.
Sleep apnea syndrome (SAS) affects about 3-7% of the global population, but is often undiagnosed. It involves pauses in breathing during sleep, for at least 10 s, due to partial or total airway blockage. The current gold standard for diagnosing SAS is polysomnography (PSG), an intrusive procedure that depends on subjective assessment by expert clinicians.
View Article and Find Full Text PDFCureus
October 2024
Pulmonary Medicine, Al-Amiri Hospital, Ministry of Health, Kuwait City, KWT.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!